社区

It's been roughly three and a half months since the U.S. Food and Drug Administration (FDA) authoriz

BioNTech stock popped on Monday after reporting adjusted profit of $12.67 a share on $6.24 billion in second-quarter sales.

The United States Securities and Exchange Commission sued the organization responsible for the development of a decentralized finance protocol over activities involved with the project for the first time.What Happened: According to a Friday SEC announcement, the agency has sued Cayman Islands-based Blockchain Credit Partners and two of its top executives over allegedly selling unregistered securities through its DeFi Money Market platform from February 2020 to February 2021. The firm purported